Cullinan Oncology Licenses U.S. Rights to the First

CAMBRIDGE, Mass., Feb. 13, 2023 (GLOBE NEWSWIRE) -- Cullinan Oncology, Inc. (Nasdaq: CGEM) and Harbour BioMed (HKEX: 02142) today announced that Cullinan...

Related Keywords

Australia ,Cambridge ,Cambridgeshire ,United Kingdom ,Australian ,Jingsong Wang ,Nadim Ahmed ,Exchange Commission ,Linkedin ,Twitter ,Cullinan Oncology Inc ,Nasdaq ,Harbour Biomed ,Cullinan Oncology ,Chief Executive Officer ,Private Securities Litigation Reform Act ,Annual Report ,Nasdaq Cgem ,